Abstract
A 39-year-old man with Candida glabrata endophthalmitis was successfully treated with a 28-day course of intravenous caspofungin. Presence of underlying renal insufficiency and infection with a drug-resistant strain precluded use of amphotericin B or fluconazole. Intravitreal administration of antifungals and vitrectomy were not required. The role of caspofungin in Candida endophthalmitis is discussed.
Original language | English (US) |
---|---|
Pages (from-to) | e46-48 |
Journal | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |
Volume | 40 |
Issue number | 5 |
DOIs | |
State | Published - Mar 1 2005 |
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases